Literature DB >> 1617856

Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

R E Kauffman1, G L Kearns.   

Abstract

Important advances in paediatric clinical pharmacology have been made over the past 2 decades. However, there remains a reluctance to pursue pharmacodynamic and pharmacokinetic studies in children and, consequently, many important therapeutic agents have not been adequately studied in this population. Age-related pharmacokinetic/pharmacodynamic studies are not only essential to provide optimal drug therapy for children, but are quite feasible. Usually, paediatric pharmacokinetic studies are conducted in children receiving treatment for a specific medical condition. The approach to soliciting participation of paediatric subjects requires special sensitivity to the fears and anxieties of the child and the parents. Factors influencing subject enrollment and suggestions to enhance enrollment into study protocols are discussed. Pharmacokinetic/pharmacodynamic studies require repeated measurements over time and often entail obtaining multiple blood and urine samples. Techniques for reducing sample volume and number of necessary samples while minimising the discomfort and fear associated with obtaining multiple samples include the development of highly sensitive analytical methods to measure drug concentrations in small volume samples. The number of samples obtained from individual subjects can be minimised by using pharmacokinetic analytical approaches such as the nonlinear mixed effect model (NONMEM) which allows estimation of pharmacokinetic characteristics of a population using limited data from each subject. In addition, less invasive methods to measure drug metabolism/elimination such as salivary sampling, transcutaneous collection and breath analysis have been applied to the study of certain drugs. Children are a particularly vulnerable population because of their limited cognitive abilities and dependence on adults. Thus, they must be afforded greater protection from exploitation as research subjects than that provided to adults.

Entities:  

Mesh:

Year:  1992        PMID: 1617856     DOI: 10.2165/00003088-199223010-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  93 in total

1.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

2.  Comparison of unbound and total serum theophylline concentrations with those of stimulated and unstimulated saliva in asthmatic children.

Authors:  I A Siegel; H Ben-Aryeh; D Gozal; A A Colin; R Szargel; D Laufer
Journal:  Ther Drug Monit       Date:  1990-09       Impact factor: 3.681

Review 3.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

5.  Some pitfalls in selecting descriptive pharmacokinetic models.

Authors:  T B Vree; Y A Hekster; M J Oosterbaan; E F Termond
Journal:  Drug Intell Clin Pharm       Date:  1984-09

6.  Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis.

Authors:  J L Blumer; S C Aronoff; C M Myers; C A O'Brien; J D Klinger; M D Reed
Journal:  Dev Pharmacol Ther       Date:  1985

7.  Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.

Authors:  P Somani; R S Shapiro; H Stockard; J T Higgins
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

9.  Transcutaneous theophylline collection in preterm infants.

Authors:  M G Murphy; C C Peck; D P Conner; K Zamani; G B Merenstein; D Rodden
Journal:  Clin Pharmacol Ther       Date:  1990-04       Impact factor: 6.875

10.  Aminoglycoside serum concentration sampling via central venous catheters: a potential source of clinical error.

Authors:  T R Franson; P S Ritch; E J Quebbeman
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Jan-Feb       Impact factor: 4.016

View more
  17 in total

1.  From adults to children: simulation-based choice of an appropriate sparse-sampling schedule.

Authors:  Stefanie Reif; Marcus Schultze-Mosgau; Gabriele Sutter
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

2.  Propofol infusion in children.

Authors:  D Macrae; I James
Journal:  BMJ       Date:  1992-10-17

3.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

Authors:  Laurel K Leslie; Thomas B Newman; P Joan Chesney; James M Perrin
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

5.  Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.

Authors:  W J Sam; M Aw; S H Quak; S M Lim; B G Charles; S Y Chan; P C Ho
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

6.  Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.

Authors:  Stéphane Corvaisier; Bruno Charpiat; Cyril Mounier; Martine Wallon; Gilles Leboucher; Mounzer Al Kurdi; Jean-François Chaulet; François Peyron
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.

Authors:  Celestino Obua; Urban Hellgren; Muhammed Ntale; Lars L Gustafsson; Jasper W Ogwal-Okeng; Toufigh Gordi; Markus Jerling
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

8.  Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.

Authors:  M Begoña Delgado-Charro; Richard H Guy
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

9.  Population pharmacokinetics of liposomal daunorubicin in children.

Authors:  Georg Hempel; Dirk Reinhardt; Ursula Creutzig; Joachim Boos
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

10.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.

Authors:  Djanilson Barbosa Santos; Antonio Clavenna; Maurizio Bonati; Helena Lutescia Luna Coelho
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.